Niva Bupa Health Insurance Share Price Target 2025: Can the Stock Cross ₹100?
Current Price: ₹91.00 (NSE: NIVABUPA) (As Of July 14, 2025)
Niva Bupa Health Insurance is currently trading at ₹91, showing a steady uptrend within its 52-week range of ₹68.54 to ₹109.34. As investors seek clarity on its future potential, here’s a detailed technical analysis and projected share price target for 2025.
About Niva Bupa Health Insurance
Niva Bupa is a leading health insurance provider in India, known for its comprehensive health plans and rapid growth in market share. The company operates in a sector with rising demand, especially post-pandemic, driving investor interest.
Technical Analysis Overview
| Indicator | Current Value | Signal |
|---|---|---|
| RSI (14) | ~66 | Neutral to Bullish |
| MACD | Positive | Bullish |
| ADX | ~36 | Strong Trend |
| Moving Averages (MA5 to MA200) | All Bullish | Strong Buy |
Technical Sentiment:
-
Daily: Strong Buy
-
Weekly: Buy
-
Monthly: Strong Buy
Support and Resistance Levels
-
Strong Support: ₹89.19 – ₹87.50
-
Immediate Resistance: ₹92.08 – ₹93.28
-
Breakout Resistance: ₹95.00 – ₹99.00
-
Long-Term Resistance: ₹100 – ₹105
Holding above ₹89 keeps the bullish sentiment intact, while a breakout above ₹93 can trigger further gains.
Niva Bupa Share Price Target 2025
| Timeframe | Target Range | Potential Upside |
|---|---|---|
| Short-Term | ₹92 – ₹94 | +1% to 3% |
| Medium-Term | ₹95 – ₹99 | +4% to 9% |
| Long-Term (2025) | ₹100 – ₹105 | +10% to 15% |
A clear move above ₹93, with volume support, could open the door to ₹100+ in 2025.
Trading Strategy
-
Entry Zone: ₹90 – ₹91
-
Breakout Confirmation: ₹93+
-
Target Levels: ₹94, ₹99, ₹100+
-
Stop Loss: ₹89
Risks & Caution
-
A fall below ₹89 may push the stock towards ₹87 – ₹85.
-
Market-wide corrections or regulatory changes could impact performance.
-
Resistance around ₹100 – ₹105 may take time to breach.
Quick Summary
| Metric | Value |
|---|---|
| Current Price | ₹91 |
| Technical Trend | Strong Buy |
| Key Support | ₹89 – ₹87 |
| Resistance Levels | ₹92 – ₹93.28, ₹95 – ₹99 |
| Long-Term Target | ₹100 – ₹105 |
| Risk Level | Moderate |
